Annual Cash & Cash Equivalents
$12.89 B
-$1.99 B-13.35%
December 31, 2023
Summary
- As of February 12, 2025, BNTX annual cash & cash equivalents is $12.89 billion, with the most recent change of -$1.99 billion (-13.35%) on December 31, 2023.
- During the last 3 years, BNTX annual cash & cash equivalents has risen by +$11.40 billion (+766.18%).
- BNTX annual cash & cash equivalents is now -13.35% below its all-time high of $14.88 billion, reached on December 31, 2022.
Performance
BNTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$10.75 B
-$373.07 M-3.35%
September 1, 2024
Summary
- As of February 12, 2025, BNTX quarterly cash and cash equivalents is $10.75 billion, with the most recent change of -$373.07 million (-3.35%) on September 1, 2024.
- Over the past year, BNTX quarterly cash and cash equivalents has dropped by -$2.14 billion (-16.62%).
- BNTX quarterly cash and cash equivalents is now -30.18% below its all-time high of $15.40 billion, reached on June 30, 2023.
Performance
BNTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BNTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.3% | -16.6% |
| 3 y3 years | +766.2% | +56.3% |
| 5 y5 years | +2639.1% | +2020.7% |
BNTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.3% | +572.7% | -30.2% | +460.9% |
| 5 y | 5-year | -13.3% | +2117.1% | -30.2% | +2058.2% |
| alltime | all time | -13.3% | +6144.4% | -30.2% | +3218.6% |
BioNTech SE Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.75 B(-3.4%) |
| Jun 2024 | - | $11.12 B(+14.7%) |
| Mar 2024 | - | $9.69 B(-24.8%) |
| Dec 2023 | $12.89 B(-13.4%) | $12.89 B(-9.7%) |
| Sep 2023 | - | $14.29 B(-7.2%) |
| Jun 2023 | - | $15.40 B(+16.3%) |
| Mar 2023 | - | $13.24 B(-11.0%) |
| Dec 2022 | $14.88 B(+676.4%) | $14.88 B(+12.8%) |
| Sep 2022 | - | $13.19 B(+35.3%) |
| Jun 2022 | - | $9.75 B(+41.7%) |
| Mar 2022 | - | $6.88 B(+259.0%) |
| Dec 2021 | $1.92 B | $1.92 B(-30.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $2.78 B(+155.1%) |
| Jun 2021 | - | $1.09 B(+4.1%) |
| Mar 2021 | - | $1.05 B(-29.8%) |
| Dec 2020 | $1.49 B(+156.0%) | $1.49 B(+28.0%) |
| Sep 2020 | - | $1.16 B(+80.4%) |
| Jun 2020 | - | $644.45 M(+29.4%) |
| Mar 2020 | - | $498.08 M(-14.4%) |
| Dec 2019 | $581.54 M(+23.5%) | $581.54 M(+14.7%) |
| Sep 2019 | - | $506.91 M(+56.5%) |
| Jun 2019 | - | $323.92 M(-31.2%) |
| Dec 2018 | $470.71 M(+128.0%) | $470.71 M |
| Dec 2017 | $206.48 M(-35.7%) | - |
| Dec 2016 | $321.04 M | - |
FAQ
- What is BioNTech SE annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioNTech SE?
- What is BioNTech SE annual cash & cash equivalents year-on-year change?
- What is BioNTech SE quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioNTech SE?
- What is BioNTech SE quarterly cash and cash equivalents year-on-year change?
What is BioNTech SE annual cash & cash equivalents?
The current annual cash & cash equivalents of BNTX is $12.89 B
What is the all time high annual cash & cash equivalents for BioNTech SE?
BioNTech SE all-time high annual cash & cash equivalents is $14.88 B
What is BioNTech SE annual cash & cash equivalents year-on-year change?
Over the past year, BNTX annual cash & cash equivalents has changed by -$1.99 B (-13.35%)
What is BioNTech SE quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BNTX is $10.75 B
What is the all time high quarterly cash and cash equivalents for BioNTech SE?
BioNTech SE all-time high quarterly cash and cash equivalents is $15.40 B
What is BioNTech SE quarterly cash and cash equivalents year-on-year change?
Over the past year, BNTX quarterly cash and cash equivalents has changed by -$2.14 B (-16.62%)